Haddock Jason 4
4 · Codiak BioSciences, Inc. · Filed Oct 15, 2020
Insider Transaction Report
Form 4
Haddock Jason
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-08-26+31,981→ 31,981 totalExercise: $19.47Exp: 2030-08-25→ Common Stock (31,981 underlying) - Award
Stock Option (Right to Buy)
2020-10-13+10,000→ 10,000 totalExercise: $15.00Exp: 2030-10-12→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]On October 2, 2020, the Issuer completed a 1-for-7.187 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to the Reverse Stock Split.
- [F2]This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.
- [F3]25% of this option shall vest and become exercisable on August 26, 2021, with the remainder vesting in 12 equal quarterly installments thereafter.
- [F4]This option shall vest in full upon the earlier to occur of (i) October 13, 2021, and (ii) the next annual meeting of the Issuer's stockholders.